• News

"Prototype Drug Uses Novel Mechanism To Treat Lung Cancers"

  • Oncology Times
  • New York, NY
  • (May 23, 2017)

Cells are constantly turning proteins on and off via molecular switches-phosphate molecules-that have become common drug targets. Researchers collaborated to screen a series of drug-like molecules for their ability to reactivate PP2A in lung cancer cells and prevent lung cancer tumors in mice. The prototype drug molecules were created from FDA-approved medications by Michael Ohlmeyer, PhD, an associate professor of pharmacological sciences at the Icahn School of Medicine at Mount Sinai.

- Michael Ohlmeyer, PhD, Associate Professor of Pharmacological Sciences at the Icahn School of Medicine at Mount Sinai

Learn more

Related Articles
CAR T Therapy
REsearcher using computer
Tisch NCI
Building exterior
AI-Powered tool
Doctor in lab
Doctor adjusting microscope
New York skyscraper seen from a park
New York skyscraper seen from a park
Researcher using microscope
Doctor in lab